Bumper Offer - Urjas oil Just @ Rs. 1
Levera DT 500 Tablet (10) is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Epilepsy. Secondary and off-label uses of Levera DT 500 Tablet (10) have also been mentioned below.
The optimal dosage of Levera DT 500 Tablet (10) is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Levera DT 500 Tablet (10) include Fatigue, Headache, Drowsiness. While these are the most often observed Levera DT 500 Tablet (10) side effects, there are can be others also. These have been listed below. Normally, these side effects of Levera DT 500 Tablet (10) are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Levera DT 500 Tablet (10) has a Moderate effect for pregnant women and Mild effect on lactating mothers. It is important to know if Levera DT 500 Tablet (10) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Levera DT 500 Tablet (10) related warnings section.
The section on Levera DT 500 Tablet (10) contraindications lists all such conditions.
Besides this, Levera DT 500 Tablet (10) may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to the above precautions for Levera DT 500 Tablet (10), it is important to know that it is not safe while driving, and is not habit-forming.
Levera DT 500 Tablet (10) is used to treat the following -
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Levera DT 500 Tablet (10) safe for pregnant women?
Levera can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Levera right away. Take your doctor's advice before taking it again.
Is the use of Levera DT 500 Tablet (10) safe during breastfeeding?
Breastfeeding women can take Levera as it bears very minor side effects for them.
What is the effect of Levera DT 500 Tablet (10) on the Kidneys?
Levera rarely harms the kidneys.
What is the effect of Levera DT 500 Tablet (10) on the Liver?
Side effects of Levera rarely affect the liver.
What is the effect of Levera DT 500 Tablet (10) on the Heart?
There are no any side effects of Levera for the heart.
Levera DT 500 Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Levera DT 500 Tablet (10) unless your doctor advises you to do so -
Is this Levera DT 500 Tablet (10) habit forming or addictive?
No, there is no any evidence that Levera DT 500 Tablet (10) is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Levera DT 500 Tablet (10) as you may feel sleepy.
Is it safe?
Yes, Levera DT 500 Tablet (10) is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Yes, this Levera DT 500 Tablet (10) works for mental disorders.
Interaction between Food and Levera DT 500 Tablet (10)
Taking Levera DT 500 Tablet (10) with food does not harm your health.
Interaction between Alcohol and Levera DT 500 Tablet (10)
Consumption of alcohol and Levera DT 500 Tablet (10) together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420